Asthma and COPD are widespread chronic respiratory diseases that impose a heavy social and economic burden. Traditional treatments often follow a "one-size-fits-all" approach, merely suppressing symptoms without achieving true health improvements. The MSCA Doctoral Network RESPIRE-EXCEL is set to revolutionize this by introducing precision medicine tailored to individual patients.